Your browser doesn't support javascript.
loading
ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
Wu, Beibei; Ramaiah, Arunachalam; Garcia, Gustavo; Hasiakos, Spyridon; Arumugaswami, Vaithilingaraja; Srikanth, Sonal.
Affiliation
  • Wu B; Department of Physiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Ramaiah A; Department of Ecology and Evolutionary Biology, University of California, Irvine, Irvine, CA.
  • Garcia G; Tata Institute for Genetics and Society, Center at inStem, Bangalore, Karnataka, India.
  • Hasiakos S; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Arumugaswami V; Department of Physiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Srikanth S; Division of Oral Biology and Medicine, UCLA School of Dentistry, Los Angeles, CA.
J Immunol ; 208(1): 74-84, 2022 01 01.
Article in En | MEDLINE | ID: mdl-34819389
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Respiratory Mucosa / Stromal Interaction Molecule 1 / ORAI1 Protein / SARS-CoV-2 / COVID-19 / Lung / Neoplasm Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Immunol Year: 2022 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Respiratory Mucosa / Stromal Interaction Molecule 1 / ORAI1 Protein / SARS-CoV-2 / COVID-19 / Lung / Neoplasm Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Immunol Year: 2022 Type: Article Affiliation country: Canada